House Health Hearing
Room 206 at 10:30:00

HB433 would repeal Alabama's 2019 Medication Assisted Treatment of Opioid Use Act, removing state rules and a standing working group for buprenorphine treatment in nonresidential settings.
If passed, HB433 repeals the MAT Act, which required the Alabama Board of Medical Examiners to adopt rules for prescribing and using buprenorphine to treat opioid addiction in nonresidential settings and used a standing working group to help draft those rules. This removes the state's regulatory framework and advisory group for this treatment. The repeal takes effect on the first day of the third month after the bill is passed and signed by the Governor.
Indefinitely Postpone
Substitute a Companion Bill
On Third Reading in House of Origin
Read Second Time in House of Origin
Reported Out of Committee in House of Origin
Reported Favorably from House Health
Introduced and Referred to House Health
Read First Time in House of Origin
Room 206 at 10:30:00
Source: Alabama Legislature